Pfizer is aiming to be first on the grid in the race to being a vaccine against respiratory syncytial virus (RSV) to market, after reporting results from a phase 3 trial of the jab in older
The EMA's Emergency Task Force (ETF) has recommended that EU member states can use a different regimen for Bavarian Nordic's monkeypox vaccine Imvanex/Jynneos that uses a smaller dose, to e
Monkeypox has claimed the first lives outside Africa – one in Brazil and another two in Spain – although the World Health organization (WHO) has said the outbreak remains "containable."
The EMA has extended the approved indications of Bavarian Nordic's smallpox vaccine Imvanex for monkeypox, which has now infected tens of thousands of people across dozens of countries worl
GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV) vaccine straight away, after the shot hit the mark in the much-anticipated AReSVi 006 trial in ad
The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan Africa, with cases rising above the 100-mark a few days ago and the
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<